Zoetis Inc (ZTS)
175.14
+0.51
(+0.29%)
USD |
NYSE |
Nov 15, 16:00
175.12
-0.02
(-0.01%)
After-Hours: 20:00
Zoetis Free Cash Flow (Quarterly): 784.00M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 784.00M |
| June 30, 2024 | 370.00M |
| March 31, 2024 | 455.00M |
| December 31, 2023 | 699.00M |
| September 30, 2023 | 579.00M |
| June 30, 2023 | 17.00M |
| March 31, 2023 | 326.00M |
| December 31, 2022 | 570.00M |
| September 30, 2022 | 372.00M |
| June 30, 2022 | 190.00M |
| March 31, 2022 | 194.00M |
| December 31, 2021 | 511.00M |
| September 30, 2021 | 534.00M |
| June 30, 2021 | 368.00M |
| March 31, 2021 | 323.00M |
| December 31, 2020 | 566.00M |
| September 30, 2020 | 445.00M |
| June 30, 2020 | 348.00M |
| March 31, 2020 | 314.00M |
| December 31, 2019 | 416.00M |
| September 30, 2019 | 378.00M |
| June 30, 2019 | 215.00M |
| March 31, 2019 | 326.00M |
| December 31, 2018 | 446.00M |
| September 30, 2018 | 476.00M |
| Date | Value |
|---|---|
| June 30, 2018 | 194.00M |
| March 31, 2018 | 336.00M |
| December 31, 2017 | 525.00M |
| September 30, 2017 | 391.00M |
| June 30, 2017 | 129.00M |
| March 31, 2017 | 77.00M |
| December 31, 2016 | 226.00M |
| September 30, 2016 | 182.00M |
| June 30, 2016 | 83.00M |
| March 31, 2016 | 6.00M |
| December 31, 2015 | 197.00M |
| September 30, 2015 | 152.00M |
| June 30, 2015 | 76.00M |
| March 31, 2015 | 15.00M |
| December 31, 2014 | 336.00M |
| September 30, 2014 | 61.00M |
| June 30, 2014 | 102.00M |
| March 31, 2014 | -68.00M |
| December 31, 2013 | 249.00M |
| September 30, 2013 | 59.00M |
| June 30, 2013 | -70.00M |
| March 31, 2013 | 259.00M |
| December 31, 2012 | 265.00M |
| September 30, 2012 | 48.00M |
| June 30, 2012 | 50.00M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
17.00M
Minimum
Jun 2023
784.00M
Maximum
Sep 2024
419.05M
Average
394.00M
Median
Free Cash Flow (Quarterly) Benchmarks
| Pfizer Inc | 6.063B |
| Regeneron Pharmaceuticals Inc | 1.049B |
| Vertex Pharmaceuticals Inc | 1.302B |
| Alnylam Pharmaceuticals Inc | 39.52M |
| Biomarin Pharmaceutical Inc | 200.30M |